On the heated plate, neither plasminogen nor bile alone caused fibrinolysis, but fibrinolysis was observed with a mixture of plasminogen and bile , indicating that bile contains a plasminogen activator . Bile caused lysis on the unheated calcium-rich plates, but not on the heated plates.
This difference also indicates the presence of an activator in bile. The greater fibrinolytic activity of bile on the unheated calcium-poor plates than on the unheated calcium-rich plates is due to the direct effect of the bile salts in bile . When the bile was heated no fibrinolysis was seen, suggesting that the activating agent is heat labile and not identical with bile.
II. Isolation of the Activator Fraction from Bile.
Isolation of the activator fraction was carried out on dog bile after assessing its activator activity. Gel filtration of the bile with Sephadex G-75 yielded activator fractions separate from those fractions containing bile salts. III. The Mode of Action of the Activator Fraction from Bile on Fibrin , Casein and TAMe. The mode of action of the activator obtained after gel filtration of dog bile as described above was studied with three different substrates: fibrin, casein and TAMe. The material employed was the crude extract pooled from fractions 3 to 5.
A. Assay with Fibrin.
Effect of pH and temperature:
The pH and temperature dependence of the activator fraction were tested by the fibrin plate 
DISCUSSION
As pointed out by FLEMING and NORMAN, an unheated calcium-containing fibrin plate should be used for the determination of plasminogen activators if the sample contains protein-solubilizing reagents such as urea, monochloracetic acid, lithium chloride, bile acid etc. Such fibrin, so-called fibrin-i, formed in the presence of calcium and fibrin-stabilizing factor (FSF), is a co-polymer of fibrin and FSF and is resistant to those reagents13). Bovine Fraction I (Armour) contains FSF so that the addition of calcium during clotting gives rise to the production of fibrin-i.
FLEMING and NORMAN did not observe fibrinolysis with human and dog bile when using the fibrin-i plate, except in one sample where the observed lysis was attributed to bacterial contamination.
Our samples, in which the absence of bacterial contamination had been verified by the thioglycollate medium and trypticase soy broth tests, induced fibrinolysis on unheated fibrin-i plates, but no measurable fibrinolysis on heated plates, thus indicating the presence of plasminogen activator in bile. It seems likely that previously the heat-labile activator, which we have demonstrated in bile, escaped detection. FLEMING and NORMAN stated that bile salts failed to activate proteolytic activity of plasminogen when tested by the caseinolytic technique.
It should also be considered that bile salts have a direct effect on the proteolytic activity of plasmin.
Our preliminary experiments verified that bile acids such as the sodium salts of deoxycholic, taurocholic and cholic acid inhibited the proteolytic activity of plasmin.
We obtained an active fraction, free of bile acid , after gel filtration of bile and were able to demonstrate its activating effect on plasminogen.
Our observation that the direct application of bile salts does not dissolve fibrin-i plates (in contrast to fibrin-s plates) was in agreement with FLEMING and NORMAN and supported their contention that bile salts do not have an activating action on plasminogen.
Further characterization of the enzymatic nature of this active bile fraction, which we termed bilokinase (BK), must await its purification . Our results suggest that bilokinase is a protease capable of activating human and bovine plasminogen.
It does not appear to be identical with urokinase owing to its lack of TAMe esterase activity.
Studies on the origin, release and physiological role of bilokinase in the biliary system and intestinal tract would seem to be rewarding . SUMMARY 1. A plasminogen activator was demonstrated in mammalian bile by the unheated calcium-rich fibrin plate and heated fibrin plate tests. 2. Active fraction, which was free of bile salts, was obtained from bile after gel filtration using Sephadex G-75. Some enzymatic activities of this fraction, which we termed bilokinase (BK), were studied using fibrin, casein and TAMe as substrates. 3. Our results suggest that bilokinase itself is a protease capable of caseinolysis, but only slight fibrinolysis and no TAMe hydrolysis.
The activating activity of bilokinase is demonstrable by fibrinolysis and caseinolysis, but not by TAMe hydrolysis.
Such activating activity is inhibited by trans-AMCHA, and easily inactivated by heating or pH manipulation.
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